Rational Use of Traditional Chinese Medicine Decoction Pieces in Outpatient Clinic of a Hospital

doi:10.19803/j.1672-8629.20240410

Abstract

Abstract: Objective To investigate the applications of PDCA cycle management method in the review of prescriptions for traditional Chinese medicine decoction pieces and to analyze its role in improving the rate of standard prescriptions and promoting the rational use of medicines. Methods A total of 645 prescriptions for traditional Chinese medicine decoction pieces given by the outpatient clinic between October and December 2023 were selected as the control group while the prescriptions after the first and second rounds of PDCA cycle management from January to March 2024 (612 prescriptions) and from April to June 2024 (615 prescriptions) were selected for the intervention group. The results of review of prescriptions before and after the PDCA cycle was carried out were compared to evaluate the utility of the method in improving the qualified rate of Chinese medicine prescriptions. Results After two PDCA cycles, the qualified rate of prescriptions for traditional Chinese medicine decoction pieces was significantly improved. In the first stage study group, the qualified rate of outpatient Chinese medicine prescriptions was significantly increased from 70.54% to 81.69%(P<0.05), but it did not reach the intended goal. In the second stage study group, the qualified rate of outpatient Chinese medicine prescriptions was increased to 91.87% (P<0.05). In case of diagnostic absence, lack of Chinese medicine diagnosis, lack of labeling of special decoctions, and in terms of rational use of toxic sips, the qualified rate of the second stage study group was significantly higher than that of the control group and the first stage study group(P<0.05). Conclusion The PDCA cycle management method can effectively improve the quality and rationality of traditional Chinese medicine decoction pieces.

Key words: PDCA Cycle, Traditional Chinese Medicine, Decoction Pieces, Prescription, Review, Quality Control, Rational Use of Medicines

CLC Number:

LI Yiwen, CAO Keming, LAN Yuze, SU Shuang, MA Hongliang, ZHANG Lili, CHANG Xiaohong, LI Bo. Rational Use of Traditional Chinese Medicine Decoction Pieces in Outpatient Clinic of a Hospital[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1293-1298.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240410

https://zgywjj.magtechjournal.com/EN/Y2024/V21/I11/1293

References

[1] HU CJ, CHEN ZM, WU SS, et al.Wisdom of Chinese Medical Precision[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2018, 36(1): 7-10.
[2] LIN CY. Application effect of PDCA Cycle in Rational Use Management of Antibiotics in Hospital[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2023, 16(35): 153-156.
[3] SHI YP, LI X, CUI XY, et al.Improvement in the Utilization of Intravenous Infusion in Inpatients by PDCA Cycle Method[J]. China Pharmacy(中国药房), 2022, 33(22): 2797-2800.
[4] ZHU ZP.Application of PDCA Cycle Management in the Quality Management of Prescription Dispensing of Chinese Medicine Pieces[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2023, 31(1): 163-165.
[5] National Administration of Traditional Chinese medicine (NATCM). Traditional Chinese Medicine Prescription Format and Writing Standard[N]. China Journal of Traditional Chinese Medicine(中国中医药报), 2010-10-29(003).
[6] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020: 443-446.
[7] Ministry of Public Health. Notice on Issuing the“Hospital Prescription Review Management Standards (Trial)”(北京市医疗机构处方专项点评指南试行)[S]. Ministry of Public Health, 2010.
[8] CAO JL, LI XL, MENG F, et al.Expert Consensus on Clinical Application of Chinese Herbal Medicine Decoction Pieces (first Edition)[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(13): 3238-3244.
[9] GOV. Prescription Management Measures of the Ministry of Health of the People’s Republic of China(处方管理办法)[S/OL]. (2007-03-13)[2022-04-19]. https://www.gov.cn/ziliao/flfg/2007-03/13/content_549406.htm.
[10] Ministry of Public Health. Hospital Prescription Review Management Standards(Trial)(医院处方点评管理规范试行)[S/OL]. (2013-06-05)[2022-04-19]. http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
[11] LU QW, JIAN FM, LIANG DM.Application effect of PDCA Cycle Intervention in Continuous Improvement of Prescription Quality in Our Hospital[J]. Strait Pharmaceutical Journal(海峡药学), 2022, 34(3): 147-150.
[12] WANG SM, ZHU TM, YU T, et al.Optimization of Water Extraction Process for Wenyang Tongbian Decoction by Multi-index Comprehensive Scoring Method plus Orthogonal Experiment[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2024, 44(6): 677-683.
[13] LIANG JR, MAI FY, LI CG, et al.Research Progress in Pharmacology of Evodipine[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2022, 28(10): 1457-1461.
[14] HE S, OU SP, YE LH, et al.Hepatotoxicity Mechanism of Toosendan Fructus Based on Network Pharmacology and Molecular Docking Techniques[J]. Drugs & Clinic(现代药物与临床), 2023, 38(12): 2955-2964.
[15] GOUDET C, CHI CW, TYTGAT J.An overview of Toxins and Genes From the Venom of the Asian Scorpion Buthus Martensi Karsch[J]. Toxicon, 2002, 40(9): 1239-1258.
[16] National Administration of Traditional Chinese Medicine. The Office of the State Administration of Traditional Chinese Medicine Issued the Operation Manual for Performance Appraisal of National Third-level Public Traditional Chinese Medicine Hospitals(2022 Edition)[EB/OL]. (2022-04-02)[2022-04-19]. http://yzs.satcm.gov.cn/zhengcewenjian/2022-04-02/25806.html.
[17] ZHUO JJ.Application of a Prescription Pre-Audit System in the Utilization Rate of Outpatient and Emergency Room Prescriptions for Proprietary Medicines[J]. Journal of Traditional Chinese Medicine Management(中医药管理杂志), 2023, 31(7): 90-92.